The DTC Act of 2025 mandates that direct-to-consumer advertisements for prescription drugs and biological products include a clear disclosure of.
The DTC Act of 2025 amends title XI of the Social Security Act to require direct-to-consumer advertisements for prescription drugs and biological products to include an appropriate disclosure of pricing information. This disclosure must clearly and conspicuously show the wholesale acquisition cost for a 30-day supply of the product. The requirement does not apply to drugs with a wholesale acquisition cost less than $35 for a 30-day supply. The bill also authorizes civil monetary penalties for violations and mandates rulemaking by the Secretary to enforce these requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.